Trials / Completed
CompletedNCT04776083
Radiotherapy to the Primary in Metastatic Non-small Cell Lung Cancer Patients
Role of Radiotherapy to the Primary Lesion in Metastatic Non-small Cell Lung Cancer Patients After First Line Systemic Therapy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Menoufia University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
study the effect of radiotherapy to the primary lesion after first line systemic therapy in metastatic non-small cell lung cancer patients.
Detailed description
Metastatic non-small cell lung cancer patients after receiving their first line systemic therapy according to their genetic mutation will be randomized to follow up versus radiotherapy to the primary lesion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | first line systemic therapy | first line systemic therapy according to the genetic mutation 0f the patient |
| RADIATION | 3D radiotherapy or IMRT | Hypo-fractionated radiotherapy to the primary lesion |
Timeline
- Start date
- 2020-09-25
- Primary completion
- 2023-11-25
- Completion
- 2023-11-25
- First posted
- 2021-03-01
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04776083. Inclusion in this directory is not an endorsement.